Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$734M |
| 2 |
Boeing
BA
|
+$493M |
| 3 |
Pfizer
PFE
|
+$478M |
| 4 |
UnitedHealth
UNH
|
+$440M |
| 5 |
Honeywell
HON
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.05B |
| 2 |
Advanced Micro Devices
AMD
|
+$447M |
| 3 |
TSMC
TSM
|
+$441M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 5 |
ExxonMobil
XOM
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.34% |
| 2 | Technology | 16.84% |
| 3 | Consumer Discretionary | 12.66% |
| 4 | Industrials | 10.11% |
| 5 | Consumer Staples | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Auburn National Bancorp
AUBN
$91.3M
| $212K | ﹤0.01% |
9,341
+400
| +4% | +$9.48K |
|
|
CARM
3252
DELISTED
Carisma Therapeutics
CARM
| $212K | ﹤0.01% |
68,295
+17,347
| +34% | +$165K |
|
|
ETNB
3253
DELISTED
89bio
ETNB
| $212K | ﹤0.01% |
13,900
-201,267
| -94% | -$2.62M |
|
3254
PrimeEnergy Resources
PNRG
$298M
| $212K | ﹤0.01% |
2,501
-999
| -29% | -$88.8K |
|
3255
Rani Therapeutics
RANI
$87M
| $212K | ﹤0.01% |
41,117
+2,717
| +7% | +$16.3K |
|
|
TGH
3256
DELISTED
Textainer Group Holdings limited
TGH
| $212K | ﹤0.01% |
6,600
-41,000
| -86% | -$1.34M |
|
3257
EyePoint Inc
EYPT
$1.03B
| $210K | ﹤0.01% |
71,300
+47,300
| +197% | +$169K |
|
3258
ESS Tech
GWH
$22M
| $210K | ﹤0.01% |
+10,080
| New | +$281K |
|
|
FSFG
3259
DELISTED
First Savings Financial Group
FSFG
| $209K | ﹤0.01% |
13,000
+200
| +2% | +$3.78K |
|
3260
Similarweb
SMWB
$628M
| $208K | ﹤0.01% |
30,700
+8,300
| +37% | +$53.1K |
|
|
FRMM
3261
Forum Markets
FRMM
$68.2M
| $207K | ﹤0.01% |
604
+484
| +403% | +$281K |
|
3262
Fortress Biotech
FBIO
$104M
| $207K | ﹤0.01% |
16,833
+613
| +4% | +$7.3K |
|
3263
Fidelity MSCI Information Technology Index ETF
FTEC
$19.8B
| $205K | ﹤0.01% |
+1,800
| New | +$188K |
|
3264
Pacer Global Cash Cows Dividend ETF
GCOW
$3.41B
| $205K | ﹤0.01% |
+6,100
| New | +$203K |
|
|
NAAS
3265
NaaS Technology Inc
NAAS
$55.1M
| $205K | ﹤0.01% |
60
-148
| -71% | -$248K |
|
|
DYNT
3266
DELISTED
Dynatronics Corp
DYNT
| $205K | ﹤0.01% |
140,618
-4,575
| -3% | -$9.2K |
|
|
APTO
3267
DELISTED
Aptose Biosciences, Inc.
APTO
| $205K | ﹤0.01% |
713
-369
| -34% | -$107K |
|
3268
Applied Digital
APLD
$7.89B
| $204K | ﹤0.01% |
91,100
+10,200
| +13% | +$25.4K |
|
|
CARV
3269
DELISTED
Carver Bancorp
CARV
| $203K | ﹤0.01% |
50,776
+13,676
| +37% | +$60.8K |
|
|
CMPS
3270
Compass Pathways
CMPS
$1.53B
| $203K | ﹤0.01% |
20,400
-162,500
| -89% | -$1.5M |
|
3271
Five Star Bancorp
FSBC
$1.14B
| $203K | ﹤0.01% |
+9,500
| New | +$246K |
|
3272
Kura Oncology
KURA
$800M
| $203K | ﹤0.01% |
+16,600
| New | +$207K |
|
3273
Symbotic
SYM
$5.48B
| $203K | ﹤0.01% |
+8,900
| New | +$149K |
|
|
VINC
3274
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $203K | ﹤0.01% |
9,750
+700
| +8% | +$15.7K |
|
3275
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.2B
| $202K | ﹤0.01% |
2,000
-1,900
| -49% | -$194K |
|
Similar funds
Renaissance Technologies's Q1 2023 Portfolio in Review
As of Q1 2023, Renaissance Technologies held 4,600 positions worth $75.4B, up 3.1% from $73.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2023 filing shows 524 new, 1,665 increased, 1,689 reduced and 668 closed positions. Its largest new stake was Honeywell: 1,937,917 shares worth $349M. The largest sale was Apple, an estimated $1.05B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q1 2023 buy was Honeywell: 1,937,917 shares worth $349M.
- Renaissance Technologies added most to First Republic Bank in Q1 2023, an estimated $734M increase.
- Renaissance Technologies's biggest Q1 2023 reduction was Apple, cutting an estimated $1.05B.
- Renaissance Technologies fully exited Advanced Micro Devices in Q1 2023, selling an estimated $447M.
- Renaissance Technologies's ten largest holdings make up 11% of its $75.4B portfolio in Q1 2023.
- Renaissance Technologies opened 524 new positions and closed 668 in Q1 2023.
- Renaissance Technologies's portfolio value rose 3.1% quarter-over-quarter to $75.4B.
Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.